AK

Aarif Khakoo

Chief Scientific Officer

Generate Biomedicines

Generate Biomedicines Pipeline

DrugIndicationPhase
GB-0895Severe AsthmaPhase 3
GB-4362Various (to reduce MMAE ADC toxicity)Preclinical
GB-5267Metastatic Ovarian CancerPreclinical
Multiple Preclinical ProgramsNot DisclosedPreclinical
Platform Collaboration Programs (Jan 2022)Not DisclosedDiscovery/Preclinical
Platform Collaboration Programs (Sep 2024)Not DisclosedDiscovery/Preclinical